SM

Sabby Management Portfolio holdings

AUM $12M
1-Year Est. Return 79.04%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
-79.04%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$213M
AUM Growth
+$45.1M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
183
New
Increased
Reduced
Closed

Top Buys

1 +$13.1M
2 +$10.3M
3 +$7.29M
4
XBI icon
State Street SPDR S&P Biotech ETF
XBI
+$6.72M
5
GILD icon
Gilead Sciences
GILD
+$6.04M

Top Sells

1 +$22.4M
2 +$9.33M
3 +$5.53M
4
AEGR
Aegerion Pharmaceuticals
AEGR
+$4.82M
5
TEVA icon
Teva Pharmaceuticals
TEVA
+$4.69M

Sector Composition

1 Healthcare 87.73%
2 Energy 1.29%
3 Communication Services 0%
4 Materials 0%
5 Technology 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
51
$938K 0.44%
+3,167
52
$900K 0.42%
+59
53
$858K 0.4%
8,236
-12,434
54
$857K 0.4%
57,342
-91,670
55
$766K 0.36%
+83
56
$765K 0.36%
54,000
+14,271
57
$718K 0.34%
+377,908
58
$670K 0.32%
22,262
-20,595
59
$641K 0.3%
60,726
+742
60
$625K 0.29%
+7,180
61
$608K 0.29%
3,345
+3,312
62
$589K 0.28%
+9,468
63
$570K 0.27%
+15,944
64
$556K 0.26%
2,316
-1,676
65
$506K 0.24%
+737
66
$496K 0.23%
22,538
-39,615
67
$386K 0.18%
868
-4,947
68
$360K 0.17%
+174
69
$291K 0.14%
+4,478
70
$260K 0.12%
137
+61
71
$241K 0.11%
+20,000
72
$226K 0.11%
+5,126
73
$225K 0.11%
+2,170
74
$213K 0.1%
+18,274
75
$181K 0.09%
144,935
-17,440